In addition, SMAD7 has been proved to suppress TGF-β/Smad activity by binding SMAD2/3 and prevent their activation upon TGF-β1 stimulation in cancer-associated fibroblasts (CAFs) formation26. Here, SMAD2 is linked to cancer.